The booming enterprise of anti-obesity medicine | EUROtoday
Get real time updates directly on you device, subscribe now.
QWhat is the main firm in Europe by market capitalization? The French luxurious large LVMH? Well no, that’s not the case! Since final fall, it has been Novo Nordisk. New what? Until now unknown to unusual mortals, this discreet Danish pharmaceutical laboratory, whose headquarters, resembling a white flying saucer, is situated within the northern suburbs of Copenhagen, is price greater than 407 billion euros on the inventory market – which is greater than Denmark’s GDP – in comparison with “only” 386 billion euros for its very stylish French pursuer.
The clarification: Novo Nordisk is the pioneer within the world battle of anti-obesity medicine with its star urge for food suppressant, Wegovy, based mostly on the identical energetic ingredient because the antidiabetic Ozempic, already diverted by…
https://www.lepoint.fr/sante/le-plantureux-business-des-medicaments-anti-obesite-10-05-2024-2559825_40.php